GlassScriptPrepare for your visit
Charu Kolekar
Geriatric Medicine (Internal Medicine) · Festus, MO · NPI 1811320856
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,159.04
in general payments reported to CMS, 2019-2025 · $114 in 2025
The $114 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $204.12
- Janssen Pharmaceuticals, INC $195.32
- E.R. Squibb & Sons, L.L.C. $143.67
- Allergan, INC. $132.20
- Dexcom, INC. $120.27
- Abiomed $115.69
Drugs and devices associated with these payments
Lifevest Leqvio Kerendia Pocket Eeg Device Dalvance Avycaz
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Charu Kolekar listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/5685791/charu-kolekar